Bi-allelic Variants in TKFC Encoding Triokinase/FMN Cyclase Are Associated with Cataracts and Multisystem Disease.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
06 02 2020
Historique:
received: 10 11 2019
accepted: 07 01 2020
pubmed: 1 2 2020
medline: 18 4 2020
entrez: 1 2 2020
Statut: ppublish

Résumé

We report an inborn error of metabolism caused by TKFC deficiency in two unrelated families. Rapid trio genome sequencing in family 1 and exome sequencing in family 2 excluded known genetic etiologies, and further variant analysis identified rare homozygous variants in TKFC. TKFC encodes a bifunctional enzyme involved in fructose metabolism through its glyceraldehyde kinase activity and in the generation of riboflavin cyclic 4',5'-phosphate (cyclic FMN) through an FMN lyase domain. The TKFC homozygous variants reported here are located within the FMN lyase domain. Functional assays in yeast support the deleterious effect of these variants on protein function. Shared phenotypes between affected individuals with TKFC deficiency include cataracts and developmental delay, associated with cerebellar hypoplasia in one case. Further complications observed in two affected individuals included liver dysfunction and microcytic anemia, while one had fatal cardiomyopathy with lactic acidosis following a febrile illness. We postulate that deficiency of TKFC causes disruption of endogenous fructose metabolism leading to generation of by-products that can cause cataract. In line with this, an affected individual had mildly elevated urinary galactitol, which has been linked to cataract development in the galactosemias. Further, in light of a previously reported role of TKFC in regulating innate antiviral immunity through suppression of MDA5, we speculate that deficiency of TKFC leads to impaired innate immunity in response to viral illness, which may explain the fatal illness observed in the most severely affected individual.

Identifiants

pubmed: 32004446
pii: S0002-9297(20)30005-7
doi: 10.1016/j.ajhg.2020.01.005
pmc: PMC7010975
pii:
doi:

Substances chimiques

Phosphotransferases (Alcohol Group Acceptor) EC 2.7.1.-
triokinase EC 2.7.1.28
Phosphorus-Oxygen Lyases EC 4.6.-
FMN cyclase EC 4.6.1.15

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

256-263

Subventions

Organisme : Austrian Science Fund FWF
ID : I 2741
Pays : Austria

Informations de copyright

Copyright © 2020 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Références

Int J Mol Sci. 2019 Mar 04;20(5):
pubmed: 30836629
Magn Reson Med. 2017 Jan;77(1):65-73
pubmed: 27859575
Nat Genet. 2014 May;46(5):503-509
pubmed: 24686847
Endocrinology. 2012 Aug;153(8):3633-45
pubmed: 22585831
Curr Opin Pediatr. 2019 Dec;31(6):815-820
pubmed: 31693592
Proteomics. 2007 Oct;7(20):3764-74
pubmed: 17890650
J Biol Chem. 2014 Apr 11;289(15):10620-36
pubmed: 24569995
Biochem Biophys Res Commun. 2005 Dec 30;338(4):1682-9
pubmed: 16289032
Cell Rep. 2015 Apr 14;11(2):192-200
pubmed: 25865883
Hum Mol Genet. 2010 Oct 15;19(20):3948-58
pubmed: 20656789
Cell Metab. 2018 Feb 6;27(2):351-361.e3
pubmed: 29414685
Biochim Biophys Acta. 1953 Jul;11(3):427-37
pubmed: 13093749
J Cataract Refract Surg. 2003 May;29(5):998-1004
pubmed: 12781289
J Inherit Metab Dis. 2019 Jul;42(4):608-619
pubmed: 30680745
Chem Res Toxicol. 2019 Aug 19;32(8):1722-1731
pubmed: 31328504
Age (Dordr). 2011 Sep;33(3):377-84
pubmed: 20842534
Genet Med. 2019 Mar;21(3):580-590
pubmed: 29997390
J Immunol. 2011 Feb 1;186(3):1618-26
pubmed: 21187438
J Biol Chem. 2003 Jan 17;278(3):1415-23
pubmed: 12401799
Am J Hum Genet. 2017 Oct 5;101(4):525-538
pubmed: 28942965
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8342-8347
pubmed: 28716935
Cytokine. 2008 Sep;43(3):350-8
pubmed: 18703349
Am J Hum Genet. 2012 Feb 10;90(2):314-20
pubmed: 22284826
J Med Genet. 2018 Nov;55(11):721-728
pubmed: 30049826
J Exp Med. 2017 Jul 3;214(7):1949-1972
pubmed: 28606988
J Clin Invest. 2018 Feb 1;128(2):545-555
pubmed: 29388924
J Biol Chem. 2003 Nov 28;278(48):48236-44
pubmed: 12966101
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1530-5
pubmed: 19164550
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Environ Toxicol. 2018 Mar;33(3):333-342
pubmed: 29193605
Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11706-11
pubmed: 17600090
Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2355-64
pubmed: 9804144

Auteurs

Saskia B Wortmann (SB)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria; Institute of Human Genetics, Technical University München, 81675 Munich, Germany; Institute of Human Genetics, Helmholtz Zentrum, 85764 Neuherberg, Germany.

Brigitte Meunier (B)

Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France.

Lamia Mestek-Boukhibar (L)

GOSgene Centre for Translational Omics and NIHR GOSH Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.

Florence van den Broek (F)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.

Elaina M Maldonado (EM)

Mitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.

Emma Clement (E)

Department of Clinical Genetics, North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK.

Daniel Weghuber (D)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.

Johannes Spenger (J)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.

Zdenek Jaros (Z)

Department of Pediatrics, Landesklinikum Zwettl, 3910 Zwettl, Austria.

Fatma Taha (F)

Mitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.

Wyatt W Yue (WW)

Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.

Simon J Heales (SJ)

Mitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK; Neurometabolic Unit, National Hospital for Neurology, Queen Square, London WC1N 3BG, UK; Department of Chemical Pathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.

James E Davison (JE)

Metabolic Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.

Johannes A Mayr (JA)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), 5020 Salzburg, Austria.

Shamima Rahman (S)

Mitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK; Metabolic Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK. Electronic address: shamima.rahman@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH